All News Zhejiang Tailin BioEngineering Co.,Ltd

Equities

300813

CNE100003S89

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
20.47 ^CNY	+0.49%		-3.40%	-16.52%

04-23	Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Zhejiang Tailin Medical Engineering Co., Ltd. announced that it expects to receive CNY 170 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Zhejiang Tailin Bioengineering Co.,Ltd Announces Final Dividend Implementation Per A Shares for the Year 2023, Payable on 27 May 2024	05-20	CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for 2023	04-23	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-23	CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it expects to receive CNY 170 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	12-11	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 11 May 2023	27/04/23	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Zhejiang Tailin Bioengineering Co.,Ltd. Proposes Final Cash Dividend for 2022	03/04/23	CI
Certain A Shares of Zhejiang Tailin BioEngineering Co.,Ltd are subject to a Lock-Up Agreement Ending on 15-JAN-2023.	14/01/23	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	28/08/22	CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it has received CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	08/06/22	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves the Final Cash Dividend for the Year 2021, Payable on May 18, 2022	10/05/22	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for the Year of 2021	19/04/22	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	18/04/22	CI
Zhejiang Tailin Life Science Co., Ltd. announced that it expects to receive CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	17/04/22	CI
Zhejiang Tailin Bioengineering Sells $33 Million RMB Convertible Bonds	29/12/21	MT
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	28/10/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Zhejiang Tailin BioEngineering Co.,Ltd

Equities

300813

CNE100003S89

All News

Filters